Double Bond Pharmaceuticals
Double Bond Pharmaceutical uses its proprietary drug delivery technology, BeloGal for the development of treatments for cancer, infectious diseases and other therapeutic indications. BeloGal formulations target diseased organs and are delivered intravenously or subcutaneously.
Double Bond Pharmaceutical International AB
Virdings allé 32B
75 450 Uppsala
Phone / ContactT: +46 76 164 9917